Promoter holding
64.27%
IL
Innovare Labs Private Limited - Due diligence report
A 360° intelligence report on Innovare Labs: trust score, financial health, credit view, compliance, directors, growth and distress signals …
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Innovare Labs — 360° Intelligence Report
Generated from MCA filings & public records69/100
Trust Score
Moderate
Innovare Labs is assessed as Moderate with a Trust Score of 69/100. Innovare Labs is an active private limited indian non-government company incorporated in 2012, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 13 Aug 2026 from the latest processed filings. Innovare Labs Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreModerate
69/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
81/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
25/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
25/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
75/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
60/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 25/100 Caution Indicated
- Negative operating earnings - debt service depends on external support.
- Open charges exceed net worth - secured lenders rank ahead.
- Elevated gearing (D/E 38%).
- Externally credit-rated (BBB-).
Charges position: 9 open (192.74 cr) · 0 satisfied (-).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Others | 8 | 48.0 cr |
| Hdfc Bank Limited | 1 | 48.0 cr |
Compliance Score: 81/100 Low Risk
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2024).
- Litigation present in 1 court forum(s).
- 2 active GST registration(s).
Legal cases on record (1)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| INDUKURI VENKATA SUNIL KUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MANDA VENKAT RAMANA REDDY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUNKARY VENU GOPAL | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| TADIKONDA RAVI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| ANIL KUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| INDUKURI VENKATA SUNIL KUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 6 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
54 allotment(s) · 2 transfer(s)
Promoters hold the largest single block of equity - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Innovare Labs Inc | Subsidiary Company | 74.00% |
Key managerial personnel: TADIKONDA RAVI (Whole-time director) · ANIL KUMAR (CFO) · INDUKURI VENKATA SUNIL KUMAR (CEO)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 75 · Distress 60
Growth signals & trust indicators
Revenue acceleration: +1.42 over 4 year(s).
EPFO headcount growing - hiring signal.
Operating for 14+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
Losses deepening year-on-year.
9 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence71/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- 2 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment39/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 9 open charge(s) of 192.74 cr already registered.
- Compliance record supports lending.
Investor view56/100
Mixed indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
10 Jan 2023
Securities allotted
19630 Equity Shares - 19.00 Lakh raised
28 Dec 2022
Securities allotted
20663 Equity Shares - 20.00 Lakh raised
18 Nov 2022
Securities allotted
840468 Equity Shares - 8.13 cr raised
10 Nov 2022
Director ceased
Subrat Sahoo
17 Mar 2022
Charge created
Others - 8.00 cr
25 Feb 2022
Securities allotted
1480164 Equity Shares - 14.33 cr raised
29 Dec 2021
Charge created
Others - 11.68 cr
02 Nov 2021
Charge created
Others - 15.00 Lakh
11 Oct 2021
Director ceased
TADIKONDA RAVI
03 May 2021
Securities allotted
20663 Equity Shares - 20.00 Lakh raised
30 Mar 2021
Charge created
Others - 15.00 cr
24 Mar 2021
Securities allotted
197892 Equity Shares - 1.92 cr raised
04 Mar 2021
Securities allotted
198890 Equity Shares - 1.93 cr raised
10
Key Observations
Auto-generated from the data aboveRevenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
6 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of BBB- from Care.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold the largest single block of equity as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 54 security allotment(s) - amounts available in the full report.
1 overseas direct investment(s) (ODI) on record - international footprint.
| Company | CIN | Location |
|---|---|---|
| Kerala State Drugs And Pharmaceuticals Ltd | U24231KL1971SGC002389 | Alappuzha, Kerala, India |
| Adeshwar Meditex | L52390MH2007PLC169544 | Mumbai, Maharashtra, India |
| Hindcon | L24117WB1998PLC087800 | Kolkata, West Bengal, India |
| Lake Chemicals Private Limited | U85110KA1992PTC013751 | Bangalore, Karnataka, India |
| Powerspack Automation Private Limited | U29253DL2012PTC237461 | New Delhi, Delhi, India |
| Karna Paints Pvt Ltd | U74899DL1995PTC069915 | New Delhi, Delhi, India |
| Sri Vyjayanthi Labs Private Limited | U24110AP1982PTC003683 | Visakhapatnam, Andhra Pradesh, India |
| Shri Nivas (Gujarat) Laboratories Pvt Ltd | U24232BR1990PTC014539 | Patna, Bihar, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Innovare Labs before audits and certifications: compliance score 81/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Innovare Labs: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Enhanced diligence advised. Credit risk score 25/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Mixed indicators. Growth score 75/100, margin trends, ownership structure and peer set for Innovare Labs - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 69/100, distress signals and MSME payment-delay disclosures - know whether Innovare Labs pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Innovare Labs - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Innovare Labs an active company?
Innovare Labs has MCA status “Active” with a compliance score of 81/100 (Low Risk).
Is Innovare Labs financially healthy?
Innovare Labs has a Financial Health Score of 25/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Innovare Labs?
Its overall Trust Score is 69/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Innovare Labs?
Promoters hold the largest single block of equity - exact percentages are in the full report. 6 active director(s) are on record.
Does Innovare Labs have loans or charges against its assets?
9 open charge(s) are registered against its assets.
Is Innovare Labs up to date with its ROC filings?
Balance sheet slightly behind (Mar 2024). Overall compliance score: 81/100 (Low Risk).
Is it risky to lend to Innovare Labs?
Its Credit Risk Score is 25/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
